Earlier this month, the White House dropped an intellectual property bombshell, announcing that it was relaxing the Donald Trump administration's opposition to suspending patent rights related to COVID-19 vaccines.
What’s Next for Vaccine IP Waiver Proposal?
Comment
Show comments
Hide Comments
